Sight Sciences Inc (SGHT)

Feb 24, 2025

Sight Sciences stock hits 52-week low at $2.47 amid market challenges - Investing.com Nigeria

Feb 24, 2025

Feb 24, 2025

Sight Sciences to Present Comprehensive Clinical Data on - GlobeNewswire

Feb 24, 2025

Feb 24, 2025

Can This Groundbreaking Glaucoma Treatment Transform Patient Care? New Data Reveals 3-Year Outcomes - StockTitan

Feb 24, 2025

Feb 24, 2025

Sight Sciences stock hits 52-week low at $2.47 amid market challenges By Investing.com - Investing.com South Africa

Feb 24, 2025

Feb 21, 2025

Critical Contrast: Microbot Medical (NASDAQ:MBOT) vs. Sight Sciences (NASDAQ:SGHT) - Defense World

Feb 21, 2025

Feb 19, 2025

Sight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025 - The Manila Times

Feb 19, 2025

Feb 19, 2025

Can Sight Sciences Maintain Growth Momentum? Q4 Earnings Date Revealed - StockTitan

Feb 19, 2025

Feb 19, 2025

Analysts Set Sight Sciences, Inc. (NASDAQ:SGHT) Target Price at $4.68 - MarketBeat

Feb 19, 2025

Feb 19, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of “Hold” from Analysts - Defense World

Feb 19, 2025

Feb 18, 2025

Stifel maintains Buy rating and $5 target on Sight Sciences stock - Investing.com Australia

Feb 18, 2025

Feb 18, 2025

Stifel maintains Buy rating and $5 target on Sight Sciences stock By Investing.com - Investing.com South Africa

Feb 18, 2025

Feb 17, 2025

Sight sciences CTO David Badawi sells $15,081 in stock - MSN

Feb 17, 2025

Feb 16, 2025

Sight Sciences stock hits 52-week low at $2.54 amid market challenges - MSN

Feb 16, 2025

Feb 14, 2025

SG Americas Securities LLC Grows Stake in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World

Feb 14, 2025

Feb 13, 2025

Sight Sciences to Present at Citi’s 2025 Unplugged MedTech and Life Sciences Access Day - GlobeNewswire

Feb 13, 2025

Feb 13, 2025

Sight Sciences to Present at Citi's 2025 Unplugged MedTech and Life Sciences Access Day - The Manila Times

Feb 13, 2025

Feb 13, 2025

Exclusive: Sight Sciences to Unveil Latest Eye Care Innovation Strategy at Major Citi Conference - StockTitan

Feb 13, 2025

Feb 13, 2025

Sight Sciences stock hits 52-week low at $2.54 amid market challenges By Investing.com - Investing.com South Africa

Feb 13, 2025

Feb 12, 2025

Raymond James downgrades Third Harmonic Bio on uncertainty for only asset - MSN

Feb 12, 2025

Feb 12, 2025

Ivanhoe Electric shares fall on public offering of units - MSN

Feb 12, 2025

Feb 12, 2025

Amarc to acquire 100% interest in adjacent Brenda property - MSN

Feb 12, 2025

Feb 11, 2025

Stifel Nicolaus Cuts Sight Sciences (NASDAQ:SGHT) Price Target to $5.00 - MarketBeat

Feb 11, 2025

Feb 10, 2025

Dry Eye Treatment Devices Market Poised to Attain Valuation of US$ 898.78 Million By 2033 | Pharmacological Synergy Driving Demand for Advanced Dry Eye Treatment Devices Says Astute Analytica - GlobeNewswire Inc.

Feb 10, 2025

Feb 08, 2025

Stifel Nicolaus Issues Pessimistic Forecast for Sight Sciences (NASDAQ:SGHT) Stock Price - Defense World

Feb 08, 2025

Feb 07, 2025

Life Sciences Group Of The Year: Cooley - Law360

Feb 07, 2025

Feb 06, 2025

What 6 Analyst Ratings Have To Say About Sight Sciences - Benzinga

Feb 06, 2025

Jan 30, 2025

Silexion Therapeutics announces exercise of warrants for $3.3M gross proceeds - MSN

Jan 30, 2025

Jan 29, 2025

Sight Sciences executives receive salary increases and bonus targets By Investing.com - Investing.com Nigeria

Jan 29, 2025

Jan 29, 2025

Sight Sciences executives receive salary increases and bonus targets - MSN

Jan 29, 2025

Jan 29, 2025

JPMorgan Chase & Co. Acquires 53,658 Shares of Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World

Jan 29, 2025

Jan 28, 2025

Sight Sciences Enhances Executive Compensation for 2025 - TipRanks

Jan 28, 2025

Jan 28, 2025

Sight Sciences price target lowered to $5 from $5.50 at UBS - MSN

Jan 28, 2025

Jan 28, 2025

Sight Sciences (NASDAQ:SGHT) Price Target Cut to $5.00 by Analysts at UBS Group - Defense World

Jan 28, 2025

Jan 27, 2025

UBS Group Cuts Sight Sciences (NASDAQ:SGHT) Price Target to $5.00 - MarketBeat

Jan 27, 2025

Jan 25, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Receives $4.72 Average PT from Analysts - MarketBeat

Jan 25, 2025

Jan 25, 2025

The Hain Celestial Group, Inc. (NASDAQ:HAIN) Receives Consensus Recommendation of “Hold” from Analysts - Defense World

Jan 25, 2025

Jan 25, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Given Average Recommendation of “Hold” by Brokerages - Defense World

Jan 25, 2025

Jan 24, 2025

Promising US Penny Stocks To Consider In January 2025 - Simply Wall St

Jan 24, 2025

Jan 24, 2025

Have Sight Sciences Insiders Been Selling Stock? - Simply Wall St

Jan 24, 2025

Jan 23, 2025

Long Focus Capital Management, LLC Increases Stake in Sight Scie - GuruFocus.com

Jan 23, 2025

Jan 22, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) CEO Sells $72,471.48 in Stock - MarketBeat

Jan 22, 2025

Jan 22, 2025

Insider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) Insider Sells 6,922 Shares of Stock - MarketBeat

Jan 22, 2025

Jan 22, 2025

Insider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CTO Sells 5,423 Shares of Stock - MarketBeat

Jan 22, 2025

Jan 22, 2025

Sight sciences CEO Paul Badawi sells shares worth $72,570 - MSN

Jan 22, 2025

Jan 22, 2025

Sight sciences CEO Paul Badawi sells shares worth $72,570 By Investing.com - Investing.com Australia

Jan 22, 2025

Jan 22, 2025

Sight sciences chief legal officer sells shares worth $19,250 - MSN

Jan 22, 2025

Jan 22, 2025

Sight sciences CTO David Badawi sells $15,081 in stock By Investing.com - Investing.com Australia

Jan 22, 2025

Jan 21, 2025

Sight sciences chief legal officer sells shares worth $19,250 By Investing.com - Investing.com South Africa

Jan 21, 2025